Insights

Gathering insights about GentiBio…

Similar companies to GentiBio

GentiBio Tech Stack

GentiBio uses 8 technology products and services including WordPress, MySQL, jQuery Migrate, and more. Explore GentiBio's tech stack below.

WordPress
Content Management System
MySQL
Database
jQuery Migrate
Javascript Libraries
jQuery
Javascript Libraries
RSS
Miscellaneous
Microsoft
Miscellaneous
PHP
Programming Languages
Bootstrap
UI Frameworks

Media & News

GentiBio Inc. hired Mark Bach as Chief Medical Officer on Sep 30th '24.
GentiBio, a leading cell and gene therapy company specializing in engineered regulatory T cells (Tregs), announced today the appointment of Mark Bach, M.D., Ph.D. as Chief Medical Officer.
Sep 30, 2024 | www.citybiz.co
GentiBio Inc. is developing Treg therapies on Aug 1st '22.
In August 2022, GentiBio, Inc. announced that it had entered into a collaboration with Bristol Myers Squibb to develop new engineered Treg therapies to re-establish immune tolerance and repair tissue in patients living with inflammatory bowel diseases (IBD).
Nov 25, 2022 | www.digitaljournal.com
GentiBio Inc. recognized as BioSpace 2023 Best Place to Work on Nov 15th '22.
GentiBio, Inc., a biotherapeutics company developing engineered T regulatory (Treg) cells (EngTregs) therapies for autoimmune, auto-inflammatory, alloimmune and allergic diseases, announced today that it has been named a BioSpace 2023 Best Place to Work.
Nov 14, 2022 | www.gentibio.com
GentiBio Inc. is developing T regulatory cells therapies for autoimmunity, autoinflammation and allergic diseases.
"Benaroya Research Institute is working with GentiBio to develop engineered regulatory T cells to treat autoimmune and autoinflammatory diseases," Dr. Yang said.
Sep 30, 2022 | www.benaroyaresearch.org
GentiBio Inc. is developing Treg therapies on Aug 1st '22.
In August 2022, GentiBio, Inc. announced that it had entered into a collaboration with Bristol Myers Squibb to develop new engineered Treg therapies to re-establish immune tolerance and repair tissue in patients living with inflammatory bowel diseases (IBD).
Sep 25, 2022 | www.globenewswire.com
GentiBio Inc. receives financing of $1.9B.
GentiBio to receive upfront cash payment, up to $1.9 billion in potential future development and commercial milestones, and royalties
Aug 09, 2022 | www.gentibio.com
GentiBio Inc. hired Chuck Silberstein as Chief Financial Officer on Feb 10th '22.
GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology, today announced the appointment of Chuck Silberstein, M.D., MBA, as Chief Financial Officer (CFO).
Feb 10, 2022 | www.prnewswire.com

GentiBio's Email Address Formats

GentiBio uses at least 1 format(s):

GentiBio Email Formats	Example	Percentage
First.Last@gentibio.com	John.Doe@gentibio.com	94%
First@gentibio.com	John@gentibio.com	4%
FLast@gentibio.com	JDoe@gentibio.com	1%
First.Middle@gentibio.com	John.Michael@gentibio.com	1%

Frequently Asked Questions

Where is GentiBio's headquarters located?

GentiBio's main headquarters is located at 150 Cambridgepark Dr Cambridge, Massachusetts 02140 US. The company has employees across 2 continents, including North AmericaEurope.

What is GentiBio's official website and social media links?

GentiBio's official website is gentibio.com and has social profiles on LinkedIn.

How much revenue does GentiBio generate?

As of October 2024, GentiBio's annual revenue reached $15M.

What is GentiBio's SIC code NAICS code?

GentiBio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does GentiBio have currently?

As of October 2024, GentiBio has approximately 61 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: K. R.Chief Scientific Officer: T. W.Vice President Finance: H. H.. Explore GentiBio's employee directory with LeadIQ.

What industry does GentiBio belong to?

GentiBio operates in the Biotechnology Research industry.

What technology does GentiBio use?

GentiBio's tech stack includes WordPressMySQLjQuery MigratejQueryRSSMicrosoftPHPBootstrap.

What is GentiBio's email format?

GentiBio's email format typically follows the pattern of . Find more GentiBio email formats with LeadIQ.

How much funding has GentiBio raised to date?

As of October 2024, GentiBio has raised $157M in funding. The last funding round occurred on Aug 11, 2021 for $157M.

When was GentiBio founded?

GentiBio was founded in 2020.

GentiBio

Biotechnology ResearchMassachusetts, United States51-200 Employees

GentiBio, Inc., is an early stage biotherapeutics company co-founded by pioneers in Treg biology and synthetic immunology to develop engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory and allergic diseases. GentiBio's proprietary autologous and allogeneic EngTregs platform integrates key complimentary technologies needed to successfully restore immune tolerance and overcome major limitations in existing regulatory T-cell therapeutics. GentiBio is at the forefront of leveraging a unique therapeutic modality that can be used to address the fundamental cause of many diseases that result from overshooting and/or malfunctioning of the immune system.

Company Overview

Headquarters: 150 Cambridgepark Dr Cambridge, Massachusetts 02140 US
Website: gentibio.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2020
Employees: 51-200

Media & News

Funding & Financials

$157M
GentiBio has raised a total of $157M of funding over 2 rounds. Their latest funding round was raised on Aug 11, 2021 in the amount of $157M.
$10M$50M
GentiBio's revenue is in the range of $10M$50M

Funding & Financials

$157M
GentiBio has raised a total of $157M of funding over 2 rounds. Their latest funding round was raised on Aug 11, 2021 in the amount of $157M.
$10M$50M
GentiBio's revenue is in the range of $10M$50M

Company Leadership

K. R.
Chief Executive Officer
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. W.
Chief Scientific Officer
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. H.
Vice President Finance
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. C.
Vice President Of Business Development
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. T. M.
Vice President Translational Science
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

E. C.
Vice President Of Business Development
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. J.
Senior Director, Head Of Quality
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
H. K. C.
Senior Director And Head Of Program Management
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. T. M.
Vice President Translational Science
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. R.
Head Of Technical Development Operations
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for GentiBio and Millions of Other Companies
Sign up for full access to GentiBio information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to GentiBio

AsclepiX Therapeutics

MyoKardia

Passage Bio

Engrail Therapeutics

AUM Biosciences

Mölnlycke Health Care

GentiBio Tech Stack

Media & News

GentiBio Inc. hired Mark Bach as Chief Medical Officer on Sep 30th '24.

GentiBio Inc. is developing Treg therapies on Aug 1st '22.

GentiBio Inc. recognized as BioSpace 2023 Best Place to Work on Nov 15th '22.

GentiBio Inc. is developing T regulatory cells therapies for autoimmunity, autoinflammation and allergic diseases.

GentiBio Inc. is developing Treg therapies on Aug 1st '22.

GentiBio Inc. receives financing of $1.9B.

GentiBio Inc. hired Chuck Silberstein as Chief Financial Officer on Feb 10th '22.

GentiBio's Email Address Formats

Frequently Asked Questions

Where is GentiBio's headquarters located?

What is GentiBio's official website and social media links?

How much revenue does GentiBio generate?

What is GentiBio's SIC code NAICS code?

How many employees does GentiBio have currently?

What industry does GentiBio belong to?

What technology does GentiBio use?

What is GentiBio's email format?

How much funding has GentiBio raised to date?

When was GentiBio founded?

GentiBio

Company Overview

Media & News

GentiBio Inc. hired Mark Bach as Chief Medical Officer on Sep 30th '24.

GentiBio Inc. is developing Treg therapies on Aug 1st '22.

GentiBio Inc. recognized as BioSpace 2023 Best Place to Work on Nov 15th '22.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?